Baird Medical Investment Holdings Limited Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Annual Revenue Annually22.5M
Gross Margin Annually83.8%
Operating Loss Annually-25.6M
Watch Items
- U.S. Commercial Expansion and Sales Force BuildoutTrigger: Establishment of New York global headquarters and recruitment of national sales force under U.S. CEO Mark SaxtonAction: Monitor quarterly progress of U.S. commercial ramp and physician/KOL network adoption
- Mainland China Policy-Driven SlowdownTrigger: Pricing pressure and reduced procurement activity in Mainland ChinaAction: Track direct customer sales recovery and stabilization of microwave ablation (MWA) device pricing
- Global Regulatory Approvals and RegistrationsTrigger: Regulatory clearances in Argentina, Pakistan, Vietnam, and registration of AI-driven surgical softwareAction: Assess international revenue diversification outside of China
Research as of 19 Jun 2026